Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 183 (CCDC183) is a protein encoded by the CCDC183 gene, primarily expressed in the testis and specifically in developing spermatids during spermiogenesis[2][7][4]. It is essential for the formation of the cytoplasmic invagination surrounding the sperm flagellum, which enables proper compartmentalization and function of spermatozoa. Knockout studies in mice demonstrate that loss of CCDC183 results in defective sperm tail formation, abnormal sperm morphology, poor motility, and consequently, male infertility. This protein appears to operate primarily in a structural/organizational capacity during late stages of sperm cell development. While the complete molecular mechanisms are not fully elucidated due to the lack of suitable antibodies and detailed interactome data, its critical role in spermatogenesis is clear[2][3]. There are currently no known drugs or therapeutic agents targeting this protein, and it is not categorized as a classical receptor, enzyme, transporter, or transcription factor.
Not applicable. No drugs are known to act directly on this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 183 (CCDC183).